FDA Approved: COREG CR — Original Application (Waylis Therapeutics LLC)

View source ↗

Summary

FDA approved COREG CR, an extended-release formulation of carvedilol phosphate, under an original NDA from Waylis Therapeutics LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• COREG CR (carvedilol phosphate)

Snippet

ORIG AP for COREG CR (CARVEDILOL PHOSPHATE)